Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;47(9):1464-1471.
doi: 10.1111/aor.14559. Epub 2023 May 16.

Retrospective evaluation of therapeutic plasma exchange treatment in a pediatric intensive care unit: Single-center experience

Cansu Durak  1 , Ebru Guney Sahin  1 , Yasar Yusuf Can  1 , Fatih Varol  1
Affiliations

Retrospective evaluation of therapeutic plasma exchange treatment in a pediatric intensive care unit: Single-center experience

Cansu Durak et al. Artif Organs. 2023 Sep.

Abstract

Background: The aim of this study is to characterize the clinical indications, outcomes, and complications of therapeutic plasma exchange (TPE) in pediatric intensive care unit.

Methods: A retrospective study was conducted on critically ill patients who received TPE. A dataset of 672 treatments administered to 102 patients was analyzed.

Results: The most common indication for TPE was COVID-19-related clinical conditions, followed by sepsis (24.5%), neurological diseases (9.8%) and renal diseases (6.9%). None of our patients died due to TPE-related complications, and the most common complication during and after the TPE was hypotension (21.7%).

Conclusion: Although TPE is riskier to provide to critically ill children, our experience indicates that it can be performed relatively safely in critically ill children with appropriate treatment indications. In particular, indications, onset time, number of sessions and other procedures should be standardized for the pediatric age group.

Keywords: child; critical illness; plasmapheresis; sepsis.

PubMed Disclaimer

References

REFERENCES

    1. Kielstein JT, Hafer C, Zimbudzi E, Hawes S. A change for better exchange-from membrane therapeutic plasma exchange to centrifugal therapeutic plasma exchange. EMJ Nephrol. 2020;8:2-10.
    1. Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing Committee of the American Society for apheresis: the eighth special issue. J Clin Apher. 2019;34(3):171-354.
    1. Nguyen TC, Kiss JE, Goldman JR, Carcillo JA. The role of plasmapheresis in critical illness. Crit Care Clin. 2012;28:453-68.
    1. Sokolov AA, Solovyev AG. Russian pioneers of therapeutic hemapheresis and extracorporeal hemocorrection: 100-year anniversary of the world's first successful plasmapheresis. Ther Apher Dial. 2014;18:117-21.
    1. Bunchman TE. Plasmapheresis and renal replacement therapy in children. Curr Opin Pediatr. 2002;14(3):310-4. https://doi.org/10.1097/00008480-200206000-00005

LinkOut - more resources